Decentralized Trial Technology Resources

  1. 5 Essential Capabilities For Decentralized Clinical Trials 2/3/2025

    Learn how to develop and utilize a successful DCT framework, enabling your study to enhance patient access, improve data quality, and streamline study operations.

  2. Creating Success With Digital Measures 8/2/2024

    Recent research from the Tufts Center for the Study of Drug Development (CSDD) illuminated the substantial ROI of digital endpoints in clinical trials. Discover how to transform your trials today.

  3. eSource Enables Speed, Flexibility, And Higher-Quality Data 7/22/2022

    A truly integrated eSource Solution, including DDC, eCOA, and eConsent, facilitates remote or decentralized clinical trials by ingesting data from multiple sources and consolidating it into a single data set.

  4. The Pharmaceutical Industry: 2024 (And Beyond) Predictions 1/24/2024

    DCTs, RWD, IRA … our industry predictions for 2024 are filled with acronyms. As we delve into 2024, explore what trends are hot ― and not ― for the coming year, and their impact on the industry.

  5. Choosing A Digital Health Sensor Partner In Clinical Trials 10/22/2024

    Explore what your organization should consider when selecting a digital health partner and monitoring solutions for your clinical trial.

  6. Beyond The Pandemic: Why eCOAs Are Here To Stay 4/29/2022

    The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.

  7. How Electronic Source Data Revolutionizes Clinical Research 7/14/2023

    By increasing interoperability and embracing digital solutions, see how the research community can maximize the benefits offered by eSource, leading to improved trial outcomes and data quality.

  8. Understanding Decentralized Clinical Trials: FDA vs. EMA Fundamentals 9/15/2025

    Designing a global decentralized clinical trial requires understanding the differing FDA and EMA approaches to trial models and informed consent.

  9. Top Pharma Showcase Why The Digital Future Is Now 10/10/2023

    See why GSK, Syneos, and other top pharma entities are focused on a foundational digital platform approach for their future trials to deliver better patient experiences and outcomes.

  10. 4 Ways Home Visits Support Successful Rare Disease Clinical Trials 4/25/2023

    Researchers, patients, pharma, and regulators face several obstacles when designing and conducting rare disease trials. Here, we delve into the importance of home visits in rare disease clinical trials.